{
    "clinical_study": {
        "@rank": "152928", 
        "acronym": "CML1113", 
        "arm_group": {
            "arm_group_label": "CML patients"
        }, 
        "brief_summary": {
            "textblock": "The GIMEMA CML Working Party promotes a multicentric, observational, non company sponsored,\n      prospective study of Chronic Myeloid Leukemia (CML) patients treated frontline with\n      dasatinib. Patients will be followed for 5 years. This study will help the definition of\n      guidelines for the treatment of CML patients in early phases.\n\n      The primary objective of the study is to describe, in the clinical practice, the rate of\n      events leading to permanent discontinuation after 2 years of treatment with dasatinib as\n      frontline therapy in newly diagnosed CML patients."
        }, 
        "brief_title": "Front-line Treatment of BCR-ABL+ Chronic Myeloid Leukemia (CML) With Dasatinib", 
        "completion_date": {
            "#text": "September 2020", 
            "@type": "Anticipated"
        }, 
        "condition": "Chronic Myeloid Leukemia", 
        "condition_browse": {
            "mesh_term": [
                "Leukemia", 
                "Leukemia, Myeloid", 
                "Leukemia, Myelogenous, Chronic, BCR-ABL Positive"
            ]
        }, 
        "detailed_description": {
            "textblock": "The primary objective is to describe, in the clinical practice, the rate of events leading\n      to permanent discontinuation after 2 years of treatment with dasatinib as frontline therapy\n      in newly diagnosed CML patients. Imatinib mesylate, a protein tyrosine kinase inhibitor\n      (TKI) targeting BCR-ABL, has become in the last decade the standard of care for Chronic\n      Myeloid Leukaemia (CML) in chronic phase (CP)1-3. Dasatinib is a second generation TKI,\n      effective in imatinib-resistant and imatinib-intolerant patients, which demonstrated\n      superior efficacy to imatinib in early CP BCR-ABL+ CML patients 4,6,7. Most data on second\n      generation TKIs are from company-sponsored studies, generally implemented in selected\n      referral centres. The long-term outcome is still unknown. The high rate of study\n      discontinuation observed within the phase 3 study may influence the mid-term and the\n      long-term data interpretation6,7. A long-term post-marketing surveillance in large\n      independent trial is extremely important to confirm the feasibility of a frontline treatment\n      with the second generation TKI dasatinib and to evaluate the efficacy in a nationwide\n      experience. Moreover, obtaining a deep molecular response is extremely relevant in order to\n      consider TKIs discontinuation. This condition is known as \"Complete Molecular Response\"\n      (CMR) and is further defined according to the sensitivity achieved (for the definition see\n      the \"Criteria of evaluation\" section). As far as treatment discontinuation, two experiences\n      have been published so far, aimed at evaluating the persistence of the CMR after imatinib\n      discontinuation. The first was a pilot study32 where 12 patients were included. These 12\n      patients discontinued imatinib after at least 2 years of CMR (median duration of negativity,\n      32 months). Six patients displayed a molecular relapse with a detectable BCR-ABL transcript\n      at 1, 2, 3, 4, and 5 months. Imatinib was then reintroduced and led to a novel molecular\n      response. Six other patients (50%) still have an undetectable level of BCR-ABL transcript\n      after a median follow-up of 18 months (range, 9-24 months). The results of this pilot trial\n      have been confirmed and extended in a second trial, the STIM trial33: 100 patients were\n      enrolled, median follow-up 17 months, 69 patients with at least 12 months follow-up: 42\n      (61%) of these 69 patients relapsed (40 before 6 months, one patient at month 7, and one at\n      month 19). At 12 months, the probability of persistent CMR for these 69 patients was 41%\n      (95% CI 29-52). All patients who relapsed responded to reintroduction of imatinib. An\n      increase of the CMR rate could possibly translate in a higher proportion of patients\n      candidate to stopping anti-CML treatment, with higher probability of remaining disease-free\n      in the long term. Interestingly, dasatinib was able to induce higher 36-month cumulative MR4\n      and MR4.5 rates than imatinib7. The advantages of this possible future scenario could be:\n      first, the possibility of treatment discontinuation at least in patients with chronic\n      clinical adverse events; second, a potential reduction of the costs of TKI treatment (after\n      the introduction of TKI, the costs of CML treatment is increasing year by year, with the\n      increasing prevalence of CML patients).\n\n      In summary, 1) Most data on second generation TKIs are from company-sponsored studies; 2)\n      The high rate of study discontinuation observed within the phase III study may influence the\n      data interpretation; 3) A long-term post-marketing surveillance in large independent trial\n      is extremely important to confirm the efficacy in a nationwide experience; 4) The\n      persistence of CMR after TKI discontinuation have been described in selected patients with\n      \"deep\" molecular response; 5) A stable CMR is a pre-requisite for treatment discontinuation;\n      6) A detailed description of the kinetic of the molecular response, potentially related to a\n      subsequent treatment discontinuation, will be done."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Cytogenetic and/or molecular confirmed diagnosis of Ph+ and/or BCR-ABL+ CML; Age 18\n             years;\n\n          -  Early chronic phase, less than 6 months from diagnosis. Prior treatment with\n             Hydroxyurea or Anagrelide is allowed;\n\n          -  Signed written informed consent according to ICH/EU/GCP and national local laws prior\n             to any study procedures.\n\n        Exclusion Criteria:\n\n          -  Prior treatment with any protein tyrosin-kinase inhibitor (TKI) or interferon;\n\n          -  Recommendations and precautions before allocating a new CML case to dasatinib are\n             fully described in the prescribing information."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "This is a multicentre, observational, prospective study of newly diagnosed chronic phase\n        CML patients treated frontline with Dasatinib 100 mg QD."
            }
        }, 
        "enrollment": {
            "#text": "133", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "January 3, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01761890", 
            "org_study_id": "CML1113", 
            "secondary_id": "RSO ID 714"
        }, 
        "intervention": {
            "arm_group_label": "CML patients", 
            "description": "Treatment decision is at the discretion of the investigator and must not be made on the basis of this observational study. Patients should have their treatment initiated in accordance with the summary of product characteristics.", 
            "intervention_name": "Dasatinib discontinuation", 
            "intervention_type": "Behavioral"
        }, 
        "intervention_browse": {
            "mesh_term": "Dasatinib"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Chronic Myeloid Leukemia", 
            "Early phase", 
            "CML", 
            "Dasatinib"
        ], 
        "lastchanged_date": "January 30, 2014", 
        "location": [
            {
                "contact": {
                    "last_name": "Pellegrino Musto, MD, PhD"
                }, 
                "facility": {
                    "address": {
                        "city": "Rionero in Vulture", 
                        "country": "Italy", 
                        "state": "Potenza"
                    }, 
                    "name": "Centro Oncologico Basilicata"
                }, 
                "investigator": [
                    {
                        "last_name": "Pellegrino MUSTO, Pr.", 
                        "role": "Principal Investigator"
                    }, 
                    {
                        "last_name": "Giuseppe Pietrantuono, Dr.", 
                        "role": "Sub-Investigator"
                    }
                ], 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Massimo Pini"
                }, 
                "facility": {
                    "address": {
                        "city": "Alessandria", 
                        "country": "Italy"
                    }, 
                    "name": "S.O.C. di Ematologia - Azienda Ospedaliera - SS. Antonio e Biagio e Cesare Arrigo"
                }, 
                "investigator": [
                    {
                        "last_name": "Gioacchino Catania", 
                        "role": "Sub-Investigator"
                    }, 
                    {
                        "last_name": "Massimo Pini", 
                        "role": "Principal Investigator"
                    }
                ], 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Serena Rupoli"
                }, 
                "facility": {
                    "address": {
                        "city": "Ancona", 
                        "country": "Italy"
                    }, 
                    "name": "Azienda Ospedaliera - Nuovo Ospedale \"Torrette\""
                }, 
                "investigator": [
                    {
                        "last_name": "Serena Rupoli", 
                        "role": "Principal Investigator"
                    }, 
                    {
                        "last_name": "Anna Rita", 
                        "role": "Sub-Investigator"
                    }
                ], 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Catia Bigazzi"
                }, 
                "facility": {
                    "address": {
                        "city": "Ascoli", 
                        "country": "Italy"
                    }, 
                    "name": "U.O.C. Ematologia e Terapia Cellulare - Ospedale \"C. e G. Mazzoni\" di Ascoli Piceno"
                }, 
                "investigator": {
                    "last_name": "Catia Bigazzi", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Fausto Palmieri"
                }, 
                "facility": {
                    "address": {
                        "city": "Avellino", 
                        "country": "Italy"
                    }, 
                    "name": "Az.Ospedaliera S.G.Moscati"
                }, 
                "investigator": [
                    {
                        "last_name": "Fausto Palmieri", 
                        "role": "Principal Investigator"
                    }, 
                    {
                        "last_name": "Antonio Volpe", 
                        "role": "Sub-Investigator"
                    }
                ], 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Giorina Specchia"
                }, 
                "facility": {
                    "address": {
                        "city": "Bari", 
                        "country": "Italy"
                    }, 
                    "name": "UO Ematologia con trapianto-Universit\u00e0 degli Studi di Bari Aldo Moro"
                }, 
                "investigator": [
                    {
                        "last_name": "Giorgina Specchia", 
                        "role": "Principal Investigator"
                    }, 
                    {
                        "last_name": "Antonella Russo", 
                        "role": "Sub-Investigator"
                    }
                ], 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "gianantonio.rosti@unibo.it", 
                    "last_name": "Gianantonio Rosti, Dr."
                }, 
                "facility": {
                    "address": {
                        "city": "Bologna", 
                        "country": "Italy", 
                        "zip": "40138"
                    }, 
                    "name": "Azienda Ospedaliera Di Bologna Policlinico S. Orsola - Malpighi"
                }, 
                "investigator": {
                    "last_name": "Gianantonio Rosti, Dr.", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Sergio Storti"
                }, 
                "facility": {
                    "address": {
                        "city": "Campobasso", 
                        "country": "Italy"
                    }, 
                    "name": "U.O.C. di Onco-Ematologia - Centro di Ricerca e Formazione ad Alta tecnologia nelle Scienze Biomediche"
                }, 
                "investigator": [
                    {
                        "last_name": "Sergio Storti", 
                        "role": "Principal Investigator"
                    }, 
                    {
                        "last_name": "Cristiana Gasbarrino, Dr.", 
                        "role": "Sub-Investigator"
                    }
                ], 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Giuseppe Tagariello, Dr."
                }, 
                "facility": {
                    "address": {
                        "city": "Castelfranco Veneto", 
                        "country": "Italy"
                    }, 
                    "name": "US Dipartimentale - Centro per le malattie del sangue - Ospedale Civile - S.Giacomo"
                }, 
                "investigator": [
                    {
                        "last_name": "Giuseppe Tagariello, Dr.", 
                        "role": "Principal Investigator"
                    }, 
                    {
                        "last_name": "Roberto Sartori, Dr.", 
                        "role": "Sub-Investigator"
                    }
                ], 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Fabio Stagno"
                }, 
                "facility": {
                    "address": {
                        "city": "Catania", 
                        "country": "Italy"
                    }, 
                    "name": "Universit\u00e0 di Catania - Cattedra di Ematologia - Ospedale \"Ferrarotto\""
                }, 
                "investigator": {
                    "last_name": "Fabio Stagno", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Antonio Cuneo"
                }, 
                "facility": {
                    "address": {
                        "city": "Ferrara", 
                        "country": "Italy"
                    }, 
                    "name": "Azienda Ospedaliero Universitaria Arcispedale Sant'Anna Dipartimento di Scienze Mediche Sezione di Ematologia e Fisiopatologia dell'Emostasi"
                }, 
                "investigator": [
                    {
                        "last_name": "Antonio Cuneo", 
                        "role": "Principal Investigator"
                    }, 
                    {
                        "last_name": "Francesco Cavazzini", 
                        "role": "Sub-Investigator"
                    }
                ], 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Alberto BOSI, Pr."
                }, 
                "facility": {
                    "address": {
                        "city": "Firenze", 
                        "country": "Italy", 
                        "zip": "50011"
                    }, 
                    "name": "Azienda Ospedaliera di Firenze"
                }, 
                "investigator": [
                    {
                        "last_name": "Alberto BOSI, Pr.", 
                        "role": "Principal Investigator"
                    }, 
                    {
                        "last_name": "Antonella Gozzini, Dr.", 
                        "role": "Sub-Investigator"
                    }
                ], 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "e.capochiani@nord.usl6.toscana.it", 
                    "last_name": "Enrico CAPOCHIANI", 
                    "phone": "0586223111"
                }, 
                "facility": {
                    "address": {
                        "city": "Livorno", 
                        "country": "Italy"
                    }, 
                    "name": "Centro Aziendale di Ematologia ASL N. 6"
                }, 
                "investigator": {
                    "last_name": "Enrico Capochiani, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Maura Brugiatelli"
                }, 
                "facility": {
                    "address": {
                        "city": "Messina", 
                        "country": "Italy"
                    }, 
                    "name": "Divisione di Ematologia - Azienda Ospedaliera Ospedali Riuniti \"Papardo Piemonte\""
                }, 
                "investigator": [
                    {
                        "last_name": "Maura Brugiatelli", 
                        "role": "Principal Investigator"
                    }, 
                    {
                        "last_name": "Laura Nocilli", 
                        "role": "Sub-Investigator"
                    }
                ], 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Caterina Musolino"
                }, 
                "facility": {
                    "address": {
                        "city": "Messina", 
                        "country": "Italy"
                    }, 
                    "name": "Azienda Ospedaliera Universitaria - Policlinico G. Martino Dipartimento di Medicina Interna - U.O. Messina"
                }, 
                "investigator": [
                    {
                        "last_name": "Caterina Musolino", 
                        "role": "Principal Investigator"
                    }, 
                    {
                        "last_name": "Alessandro Allegra", 
                        "role": "Sub-Investigator"
                    }
                ], 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Lucia Mastrullo"
                }, 
                "facility": {
                    "address": {
                        "city": "Napoli", 
                        "country": "Italy"
                    }, 
                    "name": "Ospedale San Gennaro - ASL Napoli 1"
                }, 
                "investigator": [
                    {
                        "last_name": "Lucia Mastrullo", 
                        "role": "Principal Investigator"
                    }, 
                    {
                        "last_name": "Maria Rosaria", 
                        "role": "Sub-Investigator"
                    }
                ], 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Fabrizio Pane"
                }, 
                "facility": {
                    "address": {
                        "city": "Napoli", 
                        "country": "Italy"
                    }, 
                    "name": "zienda Ospedaliera Universitaria - Universit\u00e0 degli Studi di Napoli \"Federico II\" - Facolt\u00e0 di Medicina e Chirurgia"
                }, 
                "investigator": [
                    {
                        "last_name": "Fabrizio Pane", 
                        "role": "Principal Investigator"
                    }, 
                    {
                        "last_name": "Luigia Luciano", 
                        "role": "Sub-Investigator"
                    }
                ], 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Giovanna Rege"
                }, 
                "facility": {
                    "address": {
                        "city": "Orbassano", 
                        "country": "Italy"
                    }, 
                    "name": "Dip. di Scienze Cliniche e Biologiche - Ospedale S. Luigi Gonzaga-Medicina Interna 2"
                }, 
                "investigator": [
                    {
                        "last_name": "Giovanna Rege", 
                        "role": "Principal Investigator"
                    }, 
                    {
                        "last_name": "Carmen Fava", 
                        "role": "Sub-Investigator"
                    }
                ], 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Diamante Turri"
                }, 
                "facility": {
                    "address": {
                        "city": "Palermo", 
                        "country": "Italy"
                    }, 
                    "name": "zienda Ospedaliera Universitaria - Universit\u00e0 degli Studi di Napoli \"Federico II\" - Facolt\u00e0 di Medicina e Chirurgia"
                }, 
                "investigator": {
                    "last_name": "Diamante Turri", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Maurizio Musso"
                }, 
                "facility": {
                    "address": {
                        "city": "Palermo", 
                        "country": "Italy"
                    }, 
                    "name": "La Maddalena Casa di Cura di Alta Specialit\u00e0 Dipartimento Oncologico di III Livello"
                }, 
                "investigator": [
                    {
                        "last_name": "Maurizio Musso", 
                        "role": "Principal Investigator"
                    }, 
                    {
                        "last_name": "Ferdinando Porretto", 
                        "role": "Sub-Investigator"
                    }
                ], 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Monica Crugnola"
                }, 
                "facility": {
                    "address": {
                        "city": "Parma", 
                        "country": "Italy"
                    }, 
                    "name": "Cattedra di Ematologia CTMO Universit\u00e0 degli Studi di Parma"
                }, 
                "investigator": [
                    {
                        "last_name": "Monica Crugnola", 
                        "role": "Principal Investigator"
                    }, 
                    {
                        "last_name": "Franco Aversa", 
                        "role": "Sub-Investigator"
                    }
                ], 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Roberto Di Lorenzo"
                }, 
                "facility": {
                    "address": {
                        "city": "Pescara", 
                        "country": "Italy"
                    }, 
                    "name": "U.O. Ematologia Clinica - Azienda USL di Pescara"
                }, 
                "investigator": [
                    {
                        "last_name": "Roberto Di Lorenzo", 
                        "role": "Principal Investigator"
                    }, 
                    {
                        "last_name": "Giuseppina Ricciuti", 
                        "role": "Sub-Investigator"
                    }
                ], 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Daniele Vallisa, Dr."
                }, 
                "facility": {
                    "address": {
                        "city": "Piacenza", 
                        "country": "Italy"
                    }, 
                    "name": "Unit\u00e0 Operativa Ematologia e Centro Trapianti - Dipartimento di Oncologia ed Ematologia - AUSL Ospedale di Piacenza"
                }, 
                "investigator": [
                    {
                        "last_name": "Daniele Vallisa, Dr.", 
                        "role": "Principal Investigator"
                    }, 
                    {
                        "last_name": "Elena Trabacchi, Dr.", 
                        "role": "Sub-Investigator"
                    }
                ], 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Francesco Nobile"
                }, 
                "facility": {
                    "address": {
                        "city": "Reggio Calabria", 
                        "country": "Italy"
                    }, 
                    "name": "Dipartimento Emato-Oncologia A.O.\"Bianchi-Melacrino-Morelli\""
                }, 
                "investigator": [
                    {
                        "last_name": "Francesco Nobile", 
                        "role": "Principal Investigator"
                    }, 
                    {
                        "last_name": "Bruno Martino", 
                        "role": "Sub-Investigator"
                    }
                ], 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Paolo Avanzini"
                }, 
                "facility": {
                    "address": {
                        "city": "Reggio Emilia", 
                        "country": "Italy"
                    }, 
                    "name": "Unit\u00e0 Operativa Complessa di Ematologia - Arcispedale S. Maria Nuova"
                }, 
                "investigator": [
                    {
                        "last_name": "Paolo Avanzini", 
                        "role": "Principal Investigator"
                    }, 
                    {
                        "last_name": "Isabella Capodanno", 
                        "role": "Sub-Investigator"
                    }
                ], 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Enrico Montefusco"
                }, 
                "facility": {
                    "address": {
                        "city": "Roma", 
                        "country": "Italy"
                    }, 
                    "name": "Az. Ospedaliera \"Sant' Andrea\"-Universit\u00e0 la Sapienza Seconda Facolt\u00e0 di Medicina e Chirurgia"
                }, 
                "investigator": [
                    {
                        "last_name": "Enrico Montefusco", 
                        "role": "Principal Investigator"
                    }, 
                    {
                        "last_name": "Raffaele Porrini", 
                        "role": "Sub-Investigator"
                    }
                ], 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Leonardo Pacilli"
                }, 
                "facility": {
                    "address": {
                        "city": "Roma", 
                        "country": "Italy"
                    }, 
                    "name": "Padiglione Cesalpino - I piano - Divisione di Ematologia - Ospedale S. Camillo"
                }, 
                "investigator": {
                    "last_name": "Leonardo Pacilli", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Elisabetta Abruzzese"
                }, 
                "facility": {
                    "address": {
                        "city": "Roma", 
                        "country": "Italy"
                    }, 
                    "name": "U.O.C. Ematologia - Ospedale S.Eugenio"
                }, 
                "investigator": [
                    {
                        "last_name": "Elisabetta Abruzzese", 
                        "role": "Principal Investigator"
                    }, 
                    {
                        "last_name": "Monika Trawinska", 
                        "role": "Sub-Investigator"
                    }
                ], 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Atelda Romano, Dr."
                }, 
                "facility": {
                    "address": {
                        "city": "Roma", 
                        "country": "Italy"
                    }, 
                    "name": "S.C. di Ematologia e Trapianti - I.F.O. Istituto Nazionale Tumori Regina Elena"
                }, 
                "investigator": [
                    {
                        "last_name": "Atelda Romano, Dr.", 
                        "role": "Principal Investigator"
                    }, 
                    {
                        "last_name": "Laura Nocilli, Dr.", 
                        "role": "Sub-Investigator"
                    }
                ], 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Michele Cedrone, Dr."
                }, 
                "facility": {
                    "address": {
                        "city": "Roma", 
                        "country": "Italy"
                    }, 
                    "name": "Complesso Ospedaliero S. Giovanni Addolorata"
                }, 
                "investigator": [
                    {
                        "last_name": "Barbara Anaclerico, Dr.", 
                        "role": "Sub-Investigator"
                    }, 
                    {
                        "last_name": "Michele Cedrone, Dr.", 
                        "role": "Principal Investigator"
                    }
                ], 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Simona Sica"
                }, 
                "facility": {
                    "address": {
                        "city": "Roma", 
                        "country": "Italy"
                    }, 
                    "name": "Universit\u00e0 Cattolica del Sacro Cuore - Policlinico A. Gemelli"
                }, 
                "investigator": [
                    {
                        "last_name": "Simona Sica", 
                        "role": "Principal Investigator"
                    }, 
                    {
                        "last_name": "Federica Sor\u00e0", 
                        "role": "Sub-Investigator"
                    }
                ], 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Nicola Cascavilla"
                }, 
                "facility": {
                    "address": {
                        "city": "S. G. Rotondo", 
                        "country": "Italy"
                    }, 
                    "name": "Rotondo Istituto di Ematologia - IRCCS Ospedale Casa Sollievo della Sofferenza"
                }, 
                "investigator": [
                    {
                        "last_name": "Nicola Cascavilla", 
                        "role": "Principal Investigator"
                    }, 
                    {
                        "last_name": "Antonietta Pia", 
                        "role": "Sub-Investigator"
                    }
                ], 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Monica Bocchia"
                }, 
                "facility": {
                    "address": {
                        "city": "Siena", 
                        "country": "Italy"
                    }, 
                    "name": "U.O.C. Ematologia e Trapianti - A.O. Senese - Policlinico \" Le Scotte\""
                }, 
                "investigator": [
                    {
                        "last_name": "Monica Bocchia", 
                        "role": "Principal Investigator"
                    }, 
                    {
                        "last_name": "Lara Aprile", 
                        "role": "Sub-Investigator"
                    }
                ], 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Patrizia Pregno"
                }, 
                "facility": {
                    "address": {
                        "city": "Torino", 
                        "country": "Italy"
                    }, 
                    "name": "Dipartimento di Oncologia ed Ematologia S.C. Ematologia 2 A.O. Citt\u00e0 della Salute e della Scienza di Torino San Giovanni Battista"
                }, 
                "investigator": [
                    {
                        "last_name": "Patrizia Pregno", 
                        "role": "Principal Investigator"
                    }, 
                    {
                        "last_name": "Paola Riccomagno", 
                        "role": "Sub-Investigator"
                    }
                ], 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Mario Tiribelli"
                }, 
                "facility": {
                    "address": {
                        "city": "Udine", 
                        "country": "Italy"
                    }, 
                    "name": "Clinica Ematologica - Policlinico Universitario"
                }, 
                "investigator": [
                    {
                        "last_name": "Mario Tiribelli", 
                        "role": "Principal Investigator"
                    }, 
                    {
                        "last_name": "Luciana Marin", 
                        "role": "Sub-Investigator"
                    }
                ], 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Giovanni Pizzolo"
                }, 
                "facility": {
                    "address": {
                        "city": "Verona", 
                        "country": "Italy"
                    }, 
                    "name": "Universit\u00e0 degli Studi di Verona - A. O. - Istituti Ospitalieri di Verona- Div. di Ematologia - Policlinico G.B. Rossi"
                }, 
                "investigator": [
                    {
                        "last_name": "Giovanni Pizzolo", 
                        "role": "Principal Investigator"
                    }, 
                    {
                        "last_name": "Massimiliano Bonifacio", 
                        "role": "Sub-Investigator"
                    }
                ], 
                "status": "Not yet recruiting"
            }
        ], 
        "location_countries": {
            "country": "Italy"
        }, 
        "number_of_groups": "1", 
        "official_title": "Front-line Treatment of BCR-ABL+ Chronic Myeloid Leukemia (CML) With Dasatinib. An Observational Multicentric Study.", 
        "overall_contact": {
            "email": "p.fazi@gimema.it", 
            "last_name": "Paola Fazi, Dr."
        }, 
        "overall_contact_backup": {
            "email": "e.crea@gimema.it", 
            "last_name": "Enrico Crea"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Italy: Ethics Committee", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "September 2017", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "The cumulative rate of dasatinib permanent discontinuation by 2 years.", 
            "measure": "Number of dasatinib permanent discontinuing patients.", 
            "safety_issue": "No", 
            "time_frame": "After 2 years from study entry."
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01761890"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "The cumulative rate of dasatinib permanent discontinuation by 5 years.", 
                "measure": "Number of dasatinib permanent discontinuing patients.", 
                "safety_issue": "No", 
                "time_frame": "After 5 years from study entry."
            }, 
            {
                "description": "The rate of confirmed MR4 and MR4.5 by 24 months.", 
                "measure": "Number of confirmed MR4 and MR4.5.", 
                "safety_issue": "No", 
                "time_frame": "After 2 years from study entry."
            }, 
            {
                "description": "The rate of confirmed MR4 and MR4.5 by 60 months.", 
                "measure": "Number of confirmed MR4 and MR4.5.", 
                "safety_issue": "No", 
                "time_frame": "After 60 months from study entry."
            }, 
            {
                "description": "The stability of MR4 and MR4.5.", 
                "measure": "Number of stable MR4 and MR4.5 and characteristics.", 
                "safety_issue": "No", 
                "time_frame": "After 60 months from study entry."
            }, 
            {
                "description": "The rate of Complete Cytogenetic Response (CCgR) at 1 year.", 
                "measure": "Number of Complete Cytogenetic Responses (CCgR)", 
                "safety_issue": "No", 
                "time_frame": "After one year from study entry."
            }, 
            {
                "description": "The rate of Major Molecular Response (MMR) at 1 year.", 
                "measure": "Number of Major Molecular Response (MMR).", 
                "safety_issue": "No", 
                "time_frame": "After one year from study entry."
            }, 
            {
                "description": "The median time to response and the overall estimated probability of response (CCgR, MMR, MR4, MR4.5).", 
                "measure": "Number of days to response (CCgR, MMR, MR4, MR4.5).", 
                "safety_issue": "No", 
                "time_frame": "After 4 years from study entry."
            }, 
            {
                "measure": "Number of overal surviving patients", 
                "safety_issue": "No", 
                "time_frame": "After five years from study entry."
            }, 
            {
                "measure": "Number of progression-free survival patients.", 
                "safety_issue": "No", 
                "time_frame": "After five years from study entry."
            }, 
            {
                "measure": "Number of failure-free survival patients.", 
                "safety_issue": "No", 
                "time_frame": "After five years from study entry."
            }, 
            {
                "measure": "Number of event-free survival patients.", 
                "safety_issue": "No", 
                "time_frame": "After five years from study entry."
            }, 
            {
                "description": "Overall responses and long-term outcome according to baseline prognostic factors (including: Sokal score34, Euro score35 and EUTOS score36; presence of additional chromosomal abnormalities in Ph+ cells; BCR-ABL transcript type; comorbidity score index).", 
                "measure": "Number of responses", 
                "safety_issue": "No", 
                "time_frame": "After 7 years from study entry."
            }, 
            {
                "description": "Overall responses and long-term outcome according to BCR-ABL transcript levels and CgR at 3 months and at 6 months.", 
                "measure": "Number of responses according to BCR-ABL transcript levels.", 
                "safety_issue": "No", 
                "time_frame": "After 3 and 6 months from study entry."
            }, 
            {
                "description": "Fasting glucose modifications (diabetic and normo-glycemic patients) and HbA1C modifications (diabetic patients only) during the first 24 months.", 
                "measure": "Number of patients with fasting glucose modifications.", 
                "safety_issue": "No", 
                "time_frame": "After 24 months from study entry."
            }, 
            {
                "description": "Modifications of body mass index during treatment compared to baseline.", 
                "measure": "Number of patients with modifications of body mass index during treatment compared to baseline.", 
                "safety_issue": "No", 
                "time_frame": "After 7 years from study entry."
            }, 
            {
                "description": "Modifications of serum lipids during treatment compared to baseline.", 
                "measure": "Number of patients with modifications of serum lipids during treatment compared to baseline.", 
                "safety_issue": "No", 
                "time_frame": "After 7 years from study entry."
            }, 
            {
                "measure": "Patient reported quality of life.", 
                "safety_issue": "No", 
                "time_frame": "At 3, 6, 9, 12, 18, 24 months from study entry."
            }, 
            {
                "measure": "Number of adverse events.", 
                "safety_issue": "No", 
                "time_frame": "At 3, 6, 9, 12, 18, 24 months from study entry."
            }
        ], 
        "source": "Gruppo Italiano Malattie EMatologiche dell'Adulto", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Gruppo Italiano Malattie EMatologiche dell'Adulto", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2014", 
        "study_design": "Observational Model: Case-Only, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "January 2014"
    }
}